Physician profile
Christopher Mccoy
NPI 1063154516
$476.89
in general payments reported to CMS, 2019-2025
14 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $141.60 | 2025 | Airsupra, Farxiga, Breztri |
| Axsome Therapeutics, INC. | $41.98 | 2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.05 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $31.99 | 2025 | Trintellix |
| Dexcom, INC. | $31.37 | 2025 | Dexcom G6 Transmitter |
| Lundbeck LLC | $31.16 | 2025 | Rexulti |
| Abbvie INC. | $29.49 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.78 | 2025 | |
| Pfizer INC. | $20.93 | 2025 | |
| Corcept Therapeutics | $18.28 | 2025 | Korlym |
| Exact Sciences Corporation | $17.77 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $16.42 | 2025 | Ozempic |
| Otsuka America Pharmaceutical, INC. | $15.80 | 2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.27 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.